ENIGMA THERAPEUTICS

Owners

Goods & Services

Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders; pharmaceutical compositions for the treatment of autoimmune diseases and disorders; biotechnological preparations for medical use for the treatment of oncological diseases and disorders; biotechnological preparations for medical use for the treatment of autoimmune diseases and disorders; biotechnological preparations for the treatment of oncological diseases and disorders; biotechnological preparations for the treatment of autoimmune diseases and disorders; antibodies for veterinary use; antibodies for medical use; pharmaceutical preparations containing antigens for the treatment of oncological diseases and disorders; pharmaceutical preparations containing antigens for the treatment of autoimmune diseases and disorders; none of the aforementioned goods for dental purposes

Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development services; pharmaceutical research; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; structural and functional analysis of genomes; genetic testing for scientific research; research and development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy and therapeutics; research and development services in the field of antibodies and antigens; technological services, namely, scientific research in the field of pharmaceuticals; technological services, namely, analysis in the field of pharmaceuticals; technological services, namely, testing in the field of pharmaceuticals; laboratory research services relating to the production of monoclonal antibodies; technological services, namely, scientific research relating to manufacturing methods in the field of pharmaceuticals; advisory, information and consultancy services relating to the aforementioned services; none of the aforementioned services in relation to dentistry